Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome

Human Reproduction

Volumn 21, Issue 8, 2006, Pages 2027-2032

  Chen, Xiaoli ^a   Yang, Dongzi ^a   Li, Lin ^a   Feng, Shuying ^a   Wang, Liangan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Impaired glucose tolerance; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHINESE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREDICTION; PREVALENCE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 33747892704     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del142     Document Type: Article

References (34)

1. Arslanian SA, Lewy VD and Danadian K (2001) Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 86,66-71.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES and Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89,2745-2749.
3. Burghen GA, Givens JR and Kitabchi AE (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50,113-116.
4. Chang RJ, Nakamura RM, Judd HL and Kaplan SA (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57,356-359.
5. Coorperative Meta-Analysis Group of China Obesity Task Force (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23 (1),5-10.
6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED and Bartzis MI (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 84,4006-4011.
7. Dunaif A, Hoffman AR, Scully RE, Flier JS, Longcope C, Levy LJ and Crowley WF Jr (1985) Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Obstet Gynecol 66,545-552.
8. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK and Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22,141-146.
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26,3160-3167.
10. Flier JS, Eastman RC, Minaked KL, Matteson D and Rowe JW (1985) Canthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndrome. Diabetes 34,101-107.
11. Fujimoto W (1997) A national multicenter study to learn whether type II diabetes can be prevented: The Diabetes Prevention Program. Clin Diabetes, 13-15.
12. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM, Pagotto U and Pasquali R (2004) Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome phenotype and associated factors Diabetes 53,2353-2358.
13. Harris MI, Hadden WC, Knowler WC and Bennett PH (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 36,523-534.
14. Hua C, Li Y and Zuzhi, F (2003) Ten-years studies on diabetes mellitus (1992-2001). J Sun Yat-Sen University (Med Sciences) 24 (1),1-6.
15. Kauffman RP, Baker VM, Dimarino P, Gimpel T and Castracane VD (2002) Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations. Am J Obstet Gynecol 187,1362-1369.
16. King H and Rewers M (1993) WHO Ad Hoc Diabetes, Reporting Group: Global estimates form prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16,157-177.
17. Knochenhauer ES, Key TJ, Kahasr-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 83,3078-3082.
18. Knowler WC, Narayan KM, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Schersten B and Pettitt DJ (1995) Preventing non-insulin-dependent diabetes. Diabetes 44,483-485.
19. Lam PM, Ma RC, Cheung LP, Chow CC, Chan JC and Haines CJ (2005) Polycystic ovarian syndrome in Hong Kong Chinese women: Patient characteristics and diagnostic criteria. Hong Kong Med J 11 (5),336-341.
20. Legro RS, Finegood D and Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83,2694-2698.
21. Legro RS, Kunselman AR, Dodson WC and Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84,165-169.
22. Legro RS, Castracane D and Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: Purposes and pitfalls. Obstetr Gynecol Surv 59,141-153.
23. Lillioja S, Mott NIDDM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH and Bogardus C (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329,1988-1992.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-419.
25. Pasquali R, Venturoli S, Paradis R, Capelli M, Parenti M and Melchionda N (1982) Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm Metab Res 14,284-287.
26. Polonsky KS, Sturis J and Bell GI (1996) Non-insulin-dependent diabetes mellitus: A genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334,777-783.
27. Radziuk J (2000) Insulin sensitivity and its measurement: Structural commonalities among the methods. J Clin Endocrinol Metab 85,4426-4433.
28. Reaven GM (1988) Banting lecture 1988. Role insulin resistance in human disease. Diabetes 37,1595-1607.
29. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod 19 (1),41-47.
30. Shoupe D, Kumar DD and Lobo RA (1983) Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol 147,588-592.
31. Tuomilehto J, Knowler W and Zimmet P (1992) Primary prevention of non-insulin dependent diabetes mellitus. Diabetes Metab Rev 8,339-353.
32. Warram JH, Martin BC, Krolewski AS, Soeldner JS and Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113,909-915.
33. Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N and Rojanasakul A (2001) Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynaecol Obstet 75,177-184.
34. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications (1999) Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.